Current Trends in Management of Oral Mucositis in Cancer Treatment

about

Current Trends in Management of Oral Mucositis in Cancer Treatment

Item

http://www.wikidata.org/entity/Q47104925

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Current Trends in Management of Oral Mucositis in Cancer Treatment

@en

Current Trends in Management of Oral Mucositis in Cancer Treatment

@nl

type

Item

label

Current Trends in Management of Oral Mucositis in Cancer Treatment

@en

Current Trends in Management of Oral Mucositis in Cancer Treatment

@nl

prefLabel

Current Trends in Management of Oral Mucositis in Cancer Treatment

@en

Current Trends in Management of Oral Mucositis in Cancer Treatment

@nl

P1476

Current Trends in Management of Oral Mucositis in Cancer Treatment

@en

P2093

Aalekhya Sharma Biswas

http://www.w3.org/2001/XMLSchema#string

Abhishek Shankar

http://www.w3.org/2001/XMLSchema#string

G K Rath

http://www.w3.org/2001/XMLSchema#string

Menal Bhandari

http://www.w3.org/2001/XMLSchema#string

Narayan Adhikari

http://www.w3.org/2001/XMLSchema#string

Rashika Sachan

http://www.w3.org/2001/XMLSchema#string

Ravi Kanodia

http://www.w3.org/2001/XMLSchema#string

Shubham Roy

http://www.w3.org/2001/XMLSchema#string

P2860

Mammalian target of rapamycin inhibitor-associated stomatitis

Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis

Can the oral microflora affect oral ulcerative mucositis?

American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants.

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.

Oral bacterial community dynamics in paediatric patients with malignancies in relation to chemotherapy-related oral mucositis: a prospective study

The biologic role for nuclear factor-kappaB in disease and its potential involvement in mucosal injury associated with anti-neoplastic therapy.

Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions.

Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review.

FDA approval summary: temsirolimus as treatment for advanced renal cell carcinoma.

P304

2019-2026

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.22034/APJCP.2017.18.8.2019

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28843216

http://www.w3.org/2001/XMLSchema#string

P932

5697454

http://www.w3.org/2001/XMLSchema#string